Flagship Ventures Fund IV General Partner LLC - 11 Jul 2023 Form 4 Insider Report for Evelo Biosciences, Inc.

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 11 Jul 2023
Net transaction value: +$12,499,999
SEC form: 4
Accepted by SEC: 13 Jul 2023, 17:15:30 UTC
Prior SEC filing: 17 Oct 2022
Source filing: View source filing
Reporting owner signature: Flagship Ventures Fund IV General Partner LLC, By: /s/ Noubar B. Afeyan, Ph.D., Name: Noubar B. Afeyan, Ph.D., Title: Manager

Key filing fact

Flagship Ventures Fund IV General Partner LLC filed Form 4 for Evelo Biosciences, Inc. on 13 Jul 2023.

Key facts

This page summarizes Flagship Ventures Fund IV General Partner LLC's Form 4 filing for Evelo Biosciences, Inc..
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Jul 2023, 17:15.

Change

Previous filing in this sequence was filed on 17 Oct 2022.
Current net transaction value: +$12,499,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EVLO transaction

Common Stock

Purchase

Transaction value: $2,500,000
Shares: +1,082,251
Change %: +285%
Price: $2.31^*
Shares after: 1,461,795
Date: 11 Jul 2023
Ownership: By Flagship Ventures Fund IV, L.P.
Footnotes: F1, F2

EVLO transaction

Common Stock

Purchase

Transaction value: $2,500,000
Shares: +1,082,251
Change %: +263%
Price: $2.31^*
Shares after: 1,493,241
Date: 11 Jul 2023
Ownership: By Nutritional Health LTP Fund, L.P.
Footnotes: F1, F3

EVLO transaction

Common Stock

Purchase

Transaction value: $7,499,999
Shares: +3,246,753
Change %: +474%
Price: $2.31^*
Shares after: 3,931,685
Date: 11 Jul 2023
Ownership: By Flagship Pioneering Fund VII, L.P.
Footnotes: F1, F4

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 94,371
Date: 11 Jul 2023
Ownership: By Flagship Ventures Fund IV-Rx, L.P.
Footnotes: F5

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 274,766
Date: 11 Jul 2023
Ownership: By Flagship Ventures Opportunities Fund I, L.P.
Footnotes: F6

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 34,219
Date: 11 Jul 2023
Ownership: By Flagship VentureLabs IV LLC
Footnotes: F7

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 132,282
Date: 11 Jul 2023
Ownership: By Flagship VentureLabs V LLC
Footnotes: F8

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 210,064
Date: 11 Jul 2023
Ownership: By Flagship Ventures Fund V, L.P.
Footnotes: F9

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 80,494
Date: 11 Jul 2023
Ownership: By Flagship V VentureLabs Rx Fund, L.P.
Footnotes: F10

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 39,798
Date: 11 Jul 2023
Ownership: By Nutritional Health Side Fund, L.P.
Footnotes: F11

EVLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 179,909
Date: 11 Jul 2023
Ownership: By Nutritional Health Disruptive Innovation Fund, L.P.
Footnotes: F12

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 12 footnotes

Footnote F1

On July 11, 2023, Flagship Ventures Fund IV, L.P. ("Flagship Fund IV"), Nutritional Health LTP Fund, L.P. ("Nutritional LTP") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired 1,082,251 shares, 1,082,251 shares and 3,246,753 shares, respectively, of the Issuer's Common Stock in a private placement at a price of $2.31 per share.

Footnote F2

Shares held by Flagship Fund IV. Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of Flagship Fund IV. Noubar B. Afeyan, Ph.D. ("Dr. Afeyan") is the sole manager of Flagship Fund IV GP. Each of the reporting persons except for Flagship Fund IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F3

Shares held by Nutritional LTP. Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Nutritional LTP GP. Dr. Afeyan is the Chief Executive Officer, director and sole stockholder of Flagship Pioneering. Each of the reporting persons except for Nutritional LTP disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F4

Shares held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Each of the reporting persons except for Flagship Fund VII disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F5

Shares held by Flagship Ventures Fund IV-Rx, L.P ("Flagship Fund IV-Rx"). Flagship Fund IV GP is the general partner of Flagship Fund IV-Rx. Each of the reporting persons except for Flagship Fund IV-Rx disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F6

Shares held by Flagship Ventures Opportunities Fund I, L.P. ("Flagship Opportunities I"). Flagship Ventures Opportunities Fund I General Partner LLC ("Flagship Opportunities GP") is the general partner of Flagship Opportunities I. Dr. Afeyan is the sole manager of Flagship Opportunities GP. Each of the reporting persons except for Flagship Opportunities I disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F7

Shares held by Flagship VentureLabs IV, LLC ("VentureLabs IV"). Flagship Fund IV is the manager of VentureLabs IV. Each of the reporting persons except for VentureLabs IV disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F8

Shares held by Flagship VentureLabs V LLC ("VentureLabs V"). Flagship VentureLabs V Manager LLC ("VentureLabs V Manager") serves as manager of VentureLabs V. Flagship Pioneering is the manager of VentureLabs V Manager. Each of the reporting persons except for VentureLabs V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F9

Shares held by Flagship Ventures Fund V, L.P. ("Flagship Fund V"). Flagship Ventures Fund V General Partner LLC ("Flagship Fund V GP") is the general partner of Flagship Fund V. Dr. Afeyan serves as sole manager of Flagship Fund V. Each of the reporting persons except for Flagship Fund V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F10

Shares held by Flagship V VentureLabs Rx Fund, L.P. ("VentureLabs Rx V"). Flagship Fund V GP is the general partner of VentureLabs Rx V. Each of the reporting persons except for VentureLabs Rx V disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F11

Shares held by Nutritional Health Side Fund, L.P. ("Nutritional Health Side Fund"). Flagship Fund V GP is the general partner of Nutritional Health Side Fund. Each of the reporting persons except for Nutritional Health Side Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

Footnote F12

Shares held by Nutritional Health Disruptive Innovation Fund, L.P. ("Nutritional Innovation Fund"). Flagship Fund V GP is the general partner of Nutritional Innovation Fund. Each of the reporting persons except for Nutritional Innovation Fund disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein.

SEC remarks

On June 29, 2023, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The share amounts reported herein have been adjusted to reflect the Reverse Stock Split.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .